Junqian Zhang

Shanghai University of Traditional Chinese Medicine - Cancer Institute

Shanghai, 200032

China

SCHOLARLY PAPERS

1

DOWNLOADS

5

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Discovery of Candesartan Cilexetic as a Novel Neddylation Inhibitor for Suppressing Tumor Growth

Number of pages: 57 Posted: 30 Sep 2019
Shanghai University of Traditional Chinese Medicine - Cancer Institute, East China University of Science and Technology (ECUST) - State Key Laboratory of Bioreactor Engineering, Zhejiang University - Institute of Translational Medicine, East China University of Science and Technology (ECUST) - State Key Laboratory of Bioreactor Engineering, Chinese Academy of Sciences (CAS) - CAS Center for Excellence in Molecular Cell Science, Shanghai University of Traditional Chinese Medicine - Cancer Institute, Shanghai University of Traditional Chinese Medicine - Cancer Institute, East China University of Science and Technology (ECUST) - State Key Laboratory of Bioreactor Engineering, Shanghai University of Traditional Chinese Medicine - Cancer Institute, East China University of Science and Technology (ECUST) - State Key Laboratory of Bioreactor Engineering, Shanghai Jiao Tong University (SJTU) - Shanghai Ninth People’s Hospital, Zhejiang University - Institute of Translational Medicine, East China University of Science and Technology (ECUST) - State Key Laboratory of Bioreactor Engineering and Shanghai Jiao Tong University (SJTU) - Department of Oncology
Downloads 5 (707,875)

Abstract:

Loading...

Neddylation, drug repurposing, candesartan cilexetic, NAE inhibitor